| ANTSX | OSMCX | ANTSX / OSMCX | |
| Total Expense Ratio | 1.41 | 2.13 | 66% |
| Annual Report Gross Expense Ratio | 1.44 | 2.13 | 68% |
| Fund Existence | 11 years | 28 years | - |
| Gain YTD | 8.418 | 2.732 | 308% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 507M | 2.56B | 20% |
| Annual Yield % from dividends | 1.68 | 0.83 | 201% |
| Returns for 1 year | 35.91 | -6.51 | -551% |
| Returns for 3 years | 38.31 | -18.78 | -204% |
| Returns for 5 years | -4.29 | -38.65 | 11% |
| Returns for 10 years | 47.00 | -4.86 | -966% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIVOX | 12.83 | 0.18 | +1.42% |
| American Century International Opps A | |||
| VSFCX | 23.42 | 0.07 | +0.30% |
| Federated Hermes MDT Small Cap Value C | |||
| JFNIX | 81.99 | -0.52 | -0.63% |
| Janus Henderson Global Life Sciences I | |||
| RYEUX | 128.58 | -1.83 | -1.40% |
| Rydex Europe 1.25x Strategy H | |||
| SLRYX | 41.66 | -0.67 | -1.58% |
| SEI Large Cap Growth Y (SIMT) | |||